Literature DB >> 25103519

Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study.

Patrick G T Walker1, Feiko O ter Kuile2, Tini Garske3, Clara Menendez4, Azra C Ghani3.   

Abstract

BACKGROUND: Plasmodium falciparum infection during pregnancy leads to adverse outcomes including low birthweight; however, contemporary estimates of the potential burden of malaria in pregnancy in Africa (in the absence of interventions) are poor. We aimed to estimate the need to protect pregnant women from malaria across Africa.
METHODS: Using a mathematical model applied to estimates of the geographical distribution of P falciparum across Africa in 2010, we estimated the number of pregnant women who would have been exposed to infection that year in the absence of pregnancy-specific intervention. We then used estimates of the parity-dependent acquisition of immunity to placental infection and associated risk of low birthweight to estimate the number of women who would have been affected.
FINDINGS: We estimate that, without pregnancy-specific protection, 12·4 million pregnant women (44·9% of all 27·6 million livebirths in malaria endemic areas in Africa in 2010) would have been exposed to infection, with 11·4 million having placental infection (41·2% of all livebirths). This infection leads to an estimated 900,000 (95% credible interval [CrI] 530,000-1,240,000) low birthweight deliveries per year. Around the end of the first trimester, when the placenta becomes susceptible to infection, is a key period during which we estimate that 65·2% (95% CrI 60·9-70·0) of placental infections first occur.
INTERPRETATION: Our calculations are the only contemporary estimates of the geographical distribution of placental infection and associated low birthweight. The risk of placental infection across Africa in unprotected women is high. Prevention of malaria before conception or very early in pregnancy is predicted to greatly reduce incidence of low birthweight, especially in primigravidae. The underlying lifetime risk of low birthweight changes slowly with decreasing transmission, drawing attention to the need to maintain protection as transmission falls. FUNDING: Malaria in Pregnancy Consortium and the Bill & Melinda Gates Foundation.
Copyright © 2014 Walker et al. Open Access article distributed under the terms of CC BY. Published by .. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25103519     DOI: 10.1016/S2214-109X(14)70256-6

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  56 in total

1.  Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention.

Authors:  Meghan E Whalen; Richard Kajubi; Nona Chamankhah; Liusheng Huang; Francis Orukan; Erika Wallender; Moses R Kamya; Grant Dorsey; Prasanna Jagannathan; Philip J Rosenthal; Norah Mwebaza; Francesca T Aweeka
Journal:  Clin Pharmacol Ther       Date:  2019-07-22       Impact factor: 6.875

Review 2.  Birth weight, malnutrition and kidney-associated outcomes--a global concern.

Authors:  Valerie A Luyckx; Barry M Brenner
Journal:  Nat Rev Nephrol       Date:  2015-01-20       Impact factor: 28.314

3.  Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.

Authors:  R Kajubi; L Huang; P Jagannathan; N Chamankhah; M Were; T Ruel; C A Koss; A Kakuru; N Mwebaza; M Kamya; D Havlir; G Dorsey; P J Rosenthal; F T Aweeka
Journal:  Clin Pharmacol Ther       Date:  2017-05-30       Impact factor: 6.875

4.  A Malaria Ecology Index Predicted Spatial and Temporal Variation of Malaria Burden and Efficacy of Antimalarial Interventions Based on African Serological Data.

Authors:  Gordon C McCord; Jesse K Anttila-Hughes
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

5.  Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.

Authors:  Titus H Divala; Randy G Mungwira; Patricia M Mawindo; Osward M Nyirenda; Maxwell Kanjala; Masiye Ndaferankhande; Lufina E Tsirizani; Rhoda Masonga; Francis Muwalo; Sarah Boudová; Gail E Potter; Jessie Kennedy; Jaya Goswami; Blair J Wylie; Atis Muehlenbachs; Lughano Ndovie; Priscilla Mvula; Yamikani Mbilizi; Tamiwe Tomoka; Miriam K Laufer
Journal:  Lancet Infect Dis       Date:  2018-09-05       Impact factor: 25.071

6.  Impact of Microscopic and Submicroscopic Parasitemia During Pregnancy on Placental Malaria in a High-Transmission Setting in Uganda.

Authors:  Jessica Briggs; John Ategeka; Richard Kajubi; Teddy Ochieng; Abel Kakuru; Cephus Ssemanda; Razack Wasswa; Prasanna Jagannathan; Bryan Greenhouse; Isabel Rodriguez-Barraquer; Moses Kamya; Grant Dorsey
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

7.  Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.

Authors:  Meghna Desai; Julie Gutman; Anne L'lanziva; Kephas Otieno; Elizabeth Juma; Simon Kariuki; Peter Ouma; Vincent Were; Kayla Laserson; Abraham Katana; John Williamson; Feiko O ter Kuile
Journal:  Lancet       Date:  2015-09-28       Impact factor: 79.321

Review 8.  A New Look at Care in Pregnancy: Simple, Effective Interventions for Neglected Populations.

Authors:  Stephen Hodgins; James Tielsch; Kristen Rankin; Amber Robinson; Annie Kearns; Jacquelyn Caglia
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

9.  Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine.

Authors:  Rada M Savic; Prasanna Jagannathan; Richard Kajubi; Liusheng Huang; Nan Zhang; Moses Were; Abel Kakuru; Mary K Muhindo; Norah Mwebaza; Erika Wallender; Tamara D Clark; Bishop Opira; Moses Kamya; Diane V Havlir; Philip J Rosenthal; Grant Dorsey; Francesca T Aweeka
Journal:  Clin Infect Dis       Date:  2018-09-14       Impact factor: 9.079

10.  Iron Supplementation in Iron-Replete and Nonanemic Pregnant Women in Tanzania: A Randomized Clinical Trial.

Authors:  Analee J Etheredge; Zul Premji; Nilupa S Gunaratna; Ajibola Ibraheem Abioye; Said Aboud; Christopher Duggan; Robert Mongi; Laura Meloney; Donna Spiegelman; Drucilla Roberts; Davidson H Hamer; Wafaie W Fawzi
Journal:  JAMA Pediatr       Date:  2015-10       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.